Dtt. Chua et al., LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA - TREATMENT RESULTS FOR PATIENTS WITH COMPUTED-TOMOGRAPHY ASSESSMENT, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 379-386
Citations number
23
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To study the treatment outcome in patients with locally recur
rent nasopharyngeal carcinoma as restaged by computed tomography (CT).
Patients and Methods: One hundred forty patients with CT restaged loc
ally recurrent nasopharyngeal carcinoma were reviewed. Patients were r
c:staged at recurrence according to the AJCC stage classification with
the following distribution: T1-T2:30%, T3::19%, T4:51%. Ninety-seven
patients received reirradiation; among these 62 had external irradiati
on, 34 had brachytherapy, and 1 had both. Twelve patients received sur
gery. Thirty-one patients were treated with palliative intent and rece
ived either chemotherapy or supportive treatment only. Overall surviva
l (OAS) and performance-adjusted survival (PAS, defined as surviving w
ith a Karnofsky performance score [KPS] > 50) were calculated by Kapla
n-Meier method. Multivariate analysis was performed using the Cox mode
l. Results: The median survival for all patients was 23.8 months. Afte
r reirradiation, the 3-yr and 5-yr OAS rates were 46% and 36%, respect
ively. The corresponding PAS rates were 40% and 28%. The 3-yr OAS rate
s for recurrent T1-2, T3, and T4 disease after reirradiation were 71%,
32%, and 30%; the corresponding 5-yr OAS rates were 57%, 42%, 17%. Th
e 3-yr and 5-yr OAS rates in patients receiving palliative treatments
only were 19% and 0%, respectively. The 3-yr OAS rate after surgery wa
s 42%. In the multivariate analysis, older age, recurrent T3-4 disease
, and palliative treatment were unfavorable factors in predicting over
all survival, whereas recurrent T3-4 disease, baseline KPS < 70, and p
alliative treatment were unfavorable factors in predicting PAS. A high
complication rate was observed after reirradiation, with 34% of patie
nts developing neurological sequel. Conclusion: Aggressive treatment f
or locally recurrent nasopharyngeal carcinoma is warranted especially
for those with disease confined to the nasopharynx. Survival after ret
reatment for more extensive disease remains poor but was still superio
r to supportive treatment only. Early diagnosis of local recurrence al
lows prompt administration of treatment and is associated with better
outcome. Future studies should aim at improving the therapeutic ratio
in the retreatment of recurrent disease especially in patients with mo
re extensive local recurrence. (C) 1998 Elsevier Science Inc.